Optimizing Asparaginase Use in Acute Lymphoblastic Leukemia: A Comprehensive Program on Safety and Efficacy

Through this activity, pharmacists will be equipped with the knowledge necessary to effectively monitor patients with acute lymphoblastic leukemia for asparaginase-associated toxicities as well as ensure proper management of hypersensitivity reactions and other adverse effects.